Antiepileptic drugs /
Saved in:
| Edition: | 5th ed. |
|---|---|
| Imprint: | Philadelphia : Lippincott Williams & Wilkins, c2002. |
| Description: | xv, 968 p. : ill. ; 29 cm. |
| Language: | English |
| Subject: | Epilepsy -- Chemotherapy. Anticonvulsants. Anticonvulsants -- therapeutic use. Anticonvulsants -- pharmacology. Epilepsy -- drug therapy. Anticonvulsants. Epilepsy -- Chemotherapy. |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/4746692 |
Table of Contents:
- Contributing Authors
- Preface
- Section I.. General Principles
- 1. Principles of Antiepileptic Drug Action
- 2. Neurophysiological Effects of Antiepileptic Drugs
- 3. Discovery and Preclinical Development of Antiepileptic Drugs
- 4. New Antiepileptic Drug Development: Medical Perspective
- 5. Clinical Development of Antiepileptic Drugs: Industry Perspective
- 6. The Development of Antiepilepsy Drugs: Regulatory Perspective
- 7. Antiepileptic Drug Monotherapy in Adults: Selection and Use in New-Onset Epilepsy
- 8. Combination Therapy and Drug Interactions
- 9. Laboratory Monitoring of Antiepileptic Drugs
- 10. Safety Monitoring of Antiepileptic Drugs
- 11. Use of Antiepileptic Drugs in Children
- 12. Antiepileptic Drug Use in Women
- 13. Epilepsy in the Elderly
- 14. Treatment of Status Epilepticus
- 15. Prevention of Epileptogenesis
- Section II.. Benzodiazepines
- 16. Mechanisms of Action
- 17. Chemistry, Biotransformation, and Pharmacokinetics
- 18. Clinical Efficacy and Use in Epilepsy
- 19. Adverse Effects
- Section III.. Carbamazepine
- 20. Mechanisms of Action
- 21. Chemistry, Biotransformation, and Pharmacokinetics
- 22. Interactions with Other Drugs
- 23. Clinical Efficacy and Use in Epilepsy
- 24. Clinical Efficacy and Use in Other Neurological Disorders
- 25. Clinical Efficacy and Use in Psychiatric Disorders
- 26. Adverse Effects
- Section IV.. Felbamate
- 27. Felbamate
- Section V.. Gabapentin
- 28. Mechanisms of Action
- 29. Chemistry, Biotransformation, Pharmacokinetics, and Interactions
- 30. Clinical Use
- 31. Clinical Efficacy and Use in Other Neurological Disorders
- 32. Clinical Efficacy and Use in Psychiatric Disorders
- 33. Adverse Effects
- Section VI.. Lamotrigine
- 34. Mechanisms of Action
- 35. Chemistry, Biotransformation, and Pharmacokinetics
- 36. Interactions with Other Drugs
- 37. Clinical Efficacy and Use in Epilepsy
- 38. Efficacy and Use in Nonepileptic Disorders
- 39. Adverse Effects
- Section VII.. Levetiracetam
- 40. Mechanisms of Action
- 41. Chemistry, Biotransformation, Pharmacokinetics, and Drug Interactions
- 42. Clinical Use
- 43. Adverse Experiences
- Section VIII.. Oxcarbazepine
- 44. Mechanisms of Action
- 45. Chemistry, Biotransformation, and Pharmacokinetics
- 46. Interactions with Other Drugs
- 47. Clinical Efficacy and Use in Epilepsy
- 48. Clinical Efficacy and Use in Psychiatric Disorders
- 49. Adverse Effects
- Section IX.. Phenobarbital and Other Barbiturates
- 50. Mechanisms of Action
- 51. Chemistry, Biotransformation, and Pharmacokinetics
- 52. Interactions with Other Drugs
- 53. Clinical Efficacy and Use in Epilepsy
- 54. Clinical Efficacy and Use in Nonepileptic Disorders
- 55. Adverse Effects
- 56. Methylphenobarbital
- Section X.. Phenytoin and other Hydantoins
- 57. Mechanisms of Action
- 58. Chemistry and Biotransformation
- 59. Interactions with Other Drugs
- 60. Clinical Efficacy and Use in Epilepsy
- 61. Clinical Efficacy and Use in Other Neurological Disorders
- 62. Clinical Efficacy and Use in Psychiatric Disorders
- 63. Adverse Effects
- 64. Fosphenytoin
- Section XI.. Primidone
- 65. Primidone
- Section XII.. Succinimides
- 66. Mechanisms of Action
- 67. Ethosuximide: Chemistry, Biotransformation, Pharmacokinetics, and Drug Interactions
- 68. Clinical Efficacy and Use in Epilepsy
- 69. Adverse Effects
- 70. Methsuximide
- Section XIII.. Tiagabine
- 71. Mechanisms of Action
- 72. Chemistry, Biotransformation, and Pharmacokinetics
- 73. Drug Interactions
- 74. Clinical Efficacy and Use in Epilepsy
- 75. Clinical Efficacy and Use in Nonepileptic Disorders
- 76. Adverse Effects
- Section XIV.. Topiramate
- 77. Mechanisms of Action
- 78. Chemistry, Biotransformation, and Pharmacokinetics
- 79. Drug Interactions
- 80. Clinical Efficacy and Use in Epilepsy
- 81. Clinical Efficacy and Use in Nonepileptic Disorders
- 82. Adverse Effects
- Section XV.. Valproic Acid
- 83. Mechanisms of Action
- 84. Chemistry, Biotransformation, and Pharmacokinetics
- 85. Drug Interactions
- 86. Clinical Efficacy and Use in Epilepsy
- 87. Clinical Efficacy and Use in Other Neurological Disorders
- 88. Clinical Efficacy and Use in Psychiatric Disorders
- 89. Adverse Effects
- Section XVI.. Vigabatrin
- 90. Vigabatrin
- Section XVII.. Zonisamide
- 91. Mechanisms of Action
- 92. Chemistry, Biotransformation, and Pharmacokinetics
- 93. Drug Interactions
- 94. Clinical Efficacy and Use in Epilepsy
- 95. Adverse Effects
- Section XVIII.. Drugs in Development
- 96. Pregabalin
- 97. Rufinamide
- 98. Drugs in Early Clinical Development
- Subject Index
